Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$2.8M
Filings
71
Firms Hired
3
Active Period
2009–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Support for the Open App Markets Act (S 2710) and fair competition
Client expense: $200,000 · Firm income: —
Matched citations: S 2710
Prescription Pricing for the People Act of 2019
2020 · first_quarter · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; Fiscal Year 2021 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids; COVID-19 Response Efforts and patient monitoring; CARES Act.
Client expense: $130,000 · Firm income: —
Matched citations: HR 2376
Prescription Pricing for the People Act of 2019
2020 · first_quarter · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; Fiscal Year 2021 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids; COVID-19 Response Efforts and patient monitoring; CARES Act.
Client expense: $130,000 · Firm income: —
Matched citations: S.1227
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; Fiscal Year 2021 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids; COVID-19 Response Efforts and patient monitoring; CARES Act.
Client expense: $130,000 · Firm income: —
Matched citations: S 1895
Prescription Pricing for the People Act of 2019
2019 · fourth_quarter · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Medical device tax; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Client expense: $70,000 · Firm income: —
Matched citations: HR 2376
Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020
2019 · fourth_quarter · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Medical device tax; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Client expense: $70,000 · Firm income: —
Matched citations: H.R. 2740
Prescription Pricing for the People Act of 2019
2019 · fourth_quarter · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Medical device tax; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Client expense: $70,000 · Firm income: —
Matched citations: S.1227
Support for continuous monitoring of patients taking opioids and patient safety in general; S.1227, HR 2376 - Prescription Pricing for the People Act; S 1895: Lower Health Care Costs Act; Medical device tax; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Client expense: $70,000 · Firm income: —
Matched citations: S 1895
Prescription Pricing for the People Act of 2019
2019 · third_quarter · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids; S.1227, HR 2376 - Prescription Pricing for the People Act of 2019; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Client expense: $80,000 · Firm income: —
Matched citations: HR 2376
Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020
2019 · third_quarter · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids; S.1227, HR 2376 - Prescription Pricing for the People Act of 2019; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Client expense: $80,000 · Firm income: —
Matched citations: H.R. 2740
Prescription Pricing for the People Act of 2019
2019 · third_quarter · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids; S.1227, HR 2376 - Prescription Pricing for the People Act of 2019; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Client expense: $80,000 · Firm income: —
Matched citations: S.1227
Support for continuous monitoring of patients taking opioids; S.1227, HR 2376 - Prescription Pricing for the People Act of 2019; S 1895: Lower Health Care Costs Act; Government Purchasing Organizations (GPOs) and anticompetitive behavior; H.R. 2740: Fiscal Year 2020 Labor-Health and Human Services, Education, Defense, State-Foreign Operations, and Energy and Water Development spending bills: Proposed study of continuous monitoring for patients taking opioids.
Client expense: $80,000 · Firm income: —
Matched citations: S 1895
Prescription Pricing for the People Act of 2019
2019 · second_quarter · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids. S.1227, HR 2376 - Prescription Pricing for the People Act of 2019; Government Purchasing Organizations (GPOs) and anticompetitive behavior
Client expense: $60,000 · Firm income: —
Matched citations: HR 2376
Prescription Pricing for the People Act of 2019
2019 · second_quarter · Firm: MASIMO CORPORATION
Support for continuous monitoring of patients taking opioids. S.1227, HR 2376 - Prescription Pricing for the People Act of 2019; Government Purchasing Organizations (GPOs) and anticompetitive behavior
Client expense: $60,000 · Firm income: —
Matched citations: S.1227
Carbon Monoxide Poisoning Prevention Act
2010 · second_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R.1796-Residential Carbon Monoxide Poisoning Prevention Act H.R.479-The Wakefield Act
Client expense: — · Firm income: —
Matched citations: H.R.1796
Wakefield Act
2010 · second_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R.1796-Residential Carbon Monoxide Poisoning Prevention Act H.R.479-The Wakefield Act
Client expense: — · Firm income: —
Matched citations: H.R.479
American Middle Class Tax (AMT) Relief Act of 2007
2010 · first_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Competition in medical device industry Healthcare reform, issues relating to the medical device tax H.R.3590-The Patient Protection and Affordable Care Act H.R.4872-Health Care and Education Reconciliation Act of 2010
Client expense: — · Firm income: —
Matched citations: H.R.3590
American Middle Class Tax (AMT) Relief Act of 2007
2010 · first_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform, issues relating to the medical device tax H.R.3590-The Patient Protection and Affordable Care Act, issues relating to medical device tax H.R.4872-Health Care and Education Reconciliation Act of 2010, issues relating to medical device tax
Client expense: — · Firm income: —
Matched citations: H.R.3590
Carbon Monoxide Poisoning Prevention Act
2010 · first_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R.1796-Residential Carbon Monoxide Poisoning Prevention Act H.R.479-The Wakefield Act
Client expense: — · Firm income: —
Matched citations: H.R.1796
Wakefield Act
2010 · first_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R.1796-Residential Carbon Monoxide Poisoning Prevention Act H.R.479-The Wakefield Act
Client expense: — · Firm income: —
Matched citations: H.R.479
American Middle Class Tax (AMT) Relief Act of 2007
2009 · fourth_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform, issues relating to the medical device tax H.R.3590-The Patient Protection and Affordable Care Act
Client expense: — · Firm income: $10,000
Matched citations: H.R.3590
American Middle Class Tax (AMT) Relief Act of 2007
2009 · fourth_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Competition in medical device industry Healthcare reform, issues relating to the medical device tax H.R.3590-The Patient Protection and Affordable Care Act
Client expense: — · Firm income: $10,000
Matched citations: H.R.3590
Source: Senate LDA